Package 75834-190-01

Brand: decitabine

Generic: decitabine
NDC Package

Package Facts

Identity

Package NDC 75834-190-01
Digits Only 7583419001
Product NDC 75834-190
Product ID 75834-190_e20c2038-e61d-4c04-8b35-f2ff37a1b8d5
Description

1 VIAL in 1 CARTON (75834-190-01) / 20 mL in 1 VIAL

Marketing

Marketing Status
Marketed Since 2020-12-17
Brand decitabine
Generic decitabine
Sample Package No

Linked Drug Pages (1)

DECITABINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "e20c2038-e61d-4c04-8b35-f2ff37a1b8d5", "openfda": {"nui": ["N0000000233", "N0000175595"], "upc": ["0375834190013"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["150537a8-10ac-422d-bf33-68b1a408e566"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Nivagen Pharmaceuticals, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (75834-190-01)  / 20 mL in 1 VIAL", "package_ndc": "75834-190-01", "marketing_start_date": "20201217"}], "brand_name": "DECITABINE", "product_id": "75834-190_e20c2038-e61d-4c04-8b35-f2ff37a1b8d5", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "75834-190", "generic_name": "decitabine", "labeler_name": "Nivagen Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DECITABINE", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/20mL"}], "application_number": "ANDA212117", "marketing_category": "ANDA", "marketing_start_date": "20201217", "listing_expiration_date": "20261231"}